Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 204

Similar articles for PubMed (Select 15505150)

1.

Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial.

Brooks BR, Thisted RA, Appel SH, Bradley WG, Olney RK, Berg JE, Pope LE, Smith RA; AVP-923 ALS Study Group.

Neurology. 2004 Oct 26;63(8):1364-70.

PMID:
15505150
2.

Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis.

Panitch HS, Thisted RA, Smith RA, Wynn DR, Wymer JP, Achiron A, Vollmer TL, Mandler RN, Dietrich DW, Fletcher M, Pope LE, Berg JE, Miller A; Psuedobulbar Affect in Multiple Sclerosis Study Group.

Ann Neurol. 2006 May;59(5):780-7.

PMID:
16634036
3.

Dextromethorphan/quinidine for the treatment of pseudobulbar affect.

Patatanian E, Casselman J.

Consult Pharm. 2014 Apr;29(4):264-9. doi: 10.4140/TCP.n.2014.264. Review.

PMID:
24704895
4.

An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions.

Pattee GL, Wymer JP, Lomen-Hoerth C, Appel SH, Formella AE, Pope LE.

Curr Med Res Opin. 2014 Nov;30(11):2255-65. doi: 10.1185/03007995.2014.940040. Epub 2014 Jul 28.

PMID:
25062507
6.

Dextromethorphan/quinidine: in pseudobulbar affect.

Garnock-Jones KP.

CNS Drugs. 2011 May;25(5):435-45. doi: 10.2165/11207260-000000000-00000. Review.

PMID:
21476614
7.

Effects of dextromethorphan/quinidine on auditory event-related potentials in multiple sclerosis patients with pseudobulbar affect.

Haiman G, Pratt H, Miller A.

J Clin Psychopharmacol. 2009 Oct;29(5):444-52. doi: 10.1097/JCP.0b013e3181b5ae5c.

PMID:
19745644
8.

Treatment of pseudobulbar affect in ALS: October 26 highlight and commentary.

Hingorani VN, Kittrelle JP.

Neurology. 2005 May 24;64(10):1821; author reply 1821. No abstract available.

PMID:
15911831
9.

Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers.

Pope LE, Khalil MH, Berg JE, Stiles M, Yakatan GJ, Sellers EM.

J Clin Pharmacol. 2004 Oct;44(10):1132-42.

PMID:
15342614
10.

Treatment of pseudobulbar affect in ALS.

Smith RA, Brooks BR.

Lancet Neurol. 2005 May;4(5):270. No abstract available.

PMID:
15847840
11.

Dextromethorphan/quinidine sulfate for pseudobulbar affect.

Rosen H.

Drugs Today (Barc). 2008 Sep;44(9):661-8. doi: 10.1358/dot.2008.44.9.1258664. Review.

12.

Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.

Thisted RA, Klaff L, Schwartz SL, Wymer JP, Culligan NW, Gerard G, Pope LE, Berg JE.

Clin Ther. 2006 Oct;28(10):1607-18.

PMID:
17157116
13.

Therapeutic use of dextromethorphan: key learnings from treatment of pseudobulbar affect.

Miller A, Panitch H.

J Neurol Sci. 2007 Aug 15;259(1-2):67-73. Epub 2007 Apr 16. Review.

PMID:
17433820
14.

Randomized open-label drug-drug interaction trial of dextromethorphan/quinidine and paroxetine in healthy volunteers.

Schoedel KA, Pope LE, Sellers EM.

Clin Drug Investig. 2012 Mar 1;32(3):157-69. doi: 10.2165/11599870-000000000-00000.

PMID:
22283559
16.

Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect.

Pioro EP, Brooks BR, Cummings J, Schiffer R, Thisted RA, Wynn D, Hepner A, Kaye R; Safety, Tolerability, and Efficacy Results Trial of AVP-923 in PBA Investigators.

Ann Neurol. 2010 Nov;68(5):693-702. doi: 10.1002/ana.22093.

PMID:
20839238
17.

Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect.

Pioro EP.

Neurol Ther. 2014 Jun 17;3(1):15-28. doi: 10.1007/s40120-014-0018-5. eCollection 2014 Jun. Review.

18.

Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study.

Shaibani AI, Pope LE, Thisted R, Hepner A.

Pain Med. 2012 Feb;13(2):243-54. doi: 10.1111/j.1526-4637.2011.01316.x. Epub 2012 Feb 7.

PMID:
22314263
19.

Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials.

Sang CN, Booher S, Gilron I, Parada S, Max MB.

Anesthesiology. 2002 May;96(5):1053-61.

PMID:
11981142
20.

Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect.

Schoedel KA, Morrow SA, Sellers EM.

Neuropsychiatr Dis Treat. 2014 Jun 26;10:1161-74. doi: 10.2147/NDT.S30713. eCollection 2014. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk